Biosimilarity under stress: A forced degradation study of Remicade® and Remsima™

References

• Konara CS, Barnard RT, Hine D, Siegel E, Ferro V. The tortoise and the hare: Evolving regulatory landscapes for biosimilars. Trends Biotechnol 2016; 34(1):70-83; PMID:26620970; https://doi.org/10.1016/j.tibtech.2015.10.009
   PubMed Web of Science ®Google Scholar
• European Medicines Agency. Assessment report: Inflectra; 2013.
   Google Scholar
• U.S. Food & Drug Administration. FDA Approves Inflectra, A Biosimilar To Remicade; 2016 Apr 05. [accessed 2016 Apr 16]. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm494227.htm
   Google Scholar
• Janssen Pharmaceutical. Remicade ® [package insert]; 2015.
   Google Scholar
• Jung SK, Lee KH, Jeon JW, Lee JW, Kwon BO, Kim YJ, Bae JS, Kim D, Lee SY, Chang SJ. Physicochemical characterization of remsima®. mAbs 2014; 6(5):1163-77; PMID:25517302; https://doi.org/10.4161/mabs.32221
   PubMed Web of Science ®Google Scholar
• Celltrion, Inc. FDA Arthritis Advisory Committee. FDA Briefing Document: Arthritis Advisory Committee Meeting BLA 125544: CT-P13 a proposed biosimilar to remicade (infliximab); 2016. U.S. FDA.
   Google Scholar
• Pisupati K, Tian Y, Okbazghi S, Benet A, Ackermann R, Ford M, Saveliev S, Hosfield CM, Urh M, Carson E, et al. A multidimensional analytical comparison of Remicade and the biosimilar Remsima. Anal Chem 2017; 89(9):4838-46; PMID:28365979; https://doi.org/10.1021/acs.analchem.6b04436
   PubMed Web of Science ®Google Scholar
• Celltrion, Inc. CT-P13 (inflximab biosimilar): Briefing Document for the Arthritis Advisory Committee; 2016. U.S. FDA.
   Google Scholar
• Hawe A, Wiggenhorn M, van de Weert M, Garbe JH, Mahler H, Jiskoot W. Forced degradation of therapeutic proteins. J Pharm Sci 2012; 101(3):895-913; PMID:22083792; https://doi.org/10.1002/jps.22812
   PubMed Web of Science ®Google Scholar
• Luo Q, Joubert MK, Stevenson R, Ketchem RR, Narhi LO, Wypych J. Chemical modifications in therapeutic protein aggregates generated under different stress conditions. J Biol Chem 2011; 286(28):25134-44; PMID:21518762; https://doi.org/10.1074/jbc.M110.160440
   PubMed Web of Science ®Google Scholar
• Chan CP. Forced degradation studies: Current trends and future perspectives for protein-based therapeutics. Expert Rev Proteomics 2016; 13(7):651-8; PMID:27285431; https://doi.org/10.1080/14789450.2016.1200469
   PubMed Web of Science ®Google Scholar
• Celltrion, Inc. Remsima™ [package insert]; 2014.
   Google Scholar
• Lakowicz JR. Principles of fluorescence spectroscopy. New York City, NY: Springer Science & Business Media; 2013.
   Google Scholar
• Ohadi K, Legge RL, Budman HM. Intrinsic fluorescence-based at situ soft sensor for monitoring monoclonal antibody aggregation. Biotechnol Prog 2015; 31(5):1423-32; PMID:26137937; https://doi.org/10.1002/btpr.2140
   PubMed Web of Science ®Google Scholar
• Garidel P, Hegyi M, Bassarab S, Weichel M. A rapid, sensitive and economical assessment of monoclonal antibody conformational stability by intrinsic tryptophan fluorescence spectroscopy. Biotechnol J 2008; 3(9–10):1201-11; PMID:18702089; https://doi.org/10.1002/biot.200800091
   PubMedGoogle Scholar
• Filipe V, Jiskoot W, Basmeleh AH, Halim A, Schellekens H, Brinks V. Immunogenicity of different stressed IgG monoclonal antibody formulations in immune tolerant transgenic mice. mAbs 2012; 4(6):740-52; PMID:22951518; https://doi.org/10.4161/mabs.22066
   PubMed Web of Science ®Google Scholar
• Cathou RE, Kulczycki A, Haber E. Structural features of -immunoglobulin, antibody, and their fragments. circular dichroism studies. Biochemistry 1968; 7(11):3958-64; PMID:5722265; https://doi.org/10.1021/bi00851a024
   PubMed Web of Science ®Google Scholar
• Joshi V, Shivach T, Yadav N, Rathore AS. Circular dichroism spectroscopy as a tool for monitoring aggregation in monoclonal antibody therapeutics. Anal Chem 2014; 86(23):11606-13; PMID:25350583; https://doi.org/10.1021/ac503140j
   PubMed Web of Science ®Google Scholar
• Houde DJ, Berkowitz SA. Biophysical characterization of proteins in developing biopharmaceuticals. Boston MA: Elsevier; 2014.
   Google Scholar
• Luo Q, Joubert MK, Stevenson R, Ketchem RR, Narhi LO, Wypych J. Chemical modifications in therapeutic protein aggregates generated under different stress conditions. J Biol Chem 2011; 286(28):25134-44; PMID:21518762; https://doi.org/10.1074/jbc.M110.160440
   PubMed Web of Science ®Google Scholar
• Bertolotti-Ciarlet A, Wang W, Lownes R, Pristatsky P, Fang Y, McKelvey T, Li Y, Li Y, Drummond J, Prueksaritanont T. Impact of methionine oxidation on the binding of human IgG1 to FcRn and fcγ receptors. Mol Immunol 2009; 46(8):1878-82; PMID:19269032; https://doi.org/10.1016/j.molimm.2009.02.002
   PubMed Web of Science ®Google Scholar
• Liu D, Ren D, Huang H, Dankberg J, Rosenfeld R, Cocco MJ, Li L, Brems DN, Remmele Jr RL. Structure and stability changes of human IgG1 fc as a consequence of methionine oxidation. Biochemistry 2008; 47(18):5088-100; PMID:18407665; https://doi.org/10.1021/bi702238b
   PubMed Web of Science ®Google Scholar
• Houde D, Peng Y, Berkowitz SA, Engen JR. Post-translational modifications differentially affect IgG1 conformation and receptor binding. Mol Cell Proteomics 2010; 9(8):1716-28; PMID:20103567; https://doi.org/10.1074/mcp.M900540-MCP200
   PubMed Web of Science ®Google Scholar
• Khawli LA, Goswami S, Hutchinson R, Kwong ZW, Yang J, Wang X, Yao Z, Sreedhara A, Cano T, Tesar D, et al. Charge variants in IgG1: Isolation, characterization, in vitro binding properties and pharmacokinetics in rats. mAbs 2010; 2(6):613-24; PMID:20818176; https://doi.org/10.4161/mabs.2.6.13333
   PubMed Web of Science ®Google Scholar
• Wang W, Vlasak J, Li Y, Pristatsky P, Fang Y, Pittman T, Roman J, Wang Y, Prueksaritanont T, Ionescu R. Impact of methionine oxidation in human IgG1 fc on serum half-life of monoclonal antibodies. Mol Immunol 2011; 48(6):860-6; PMID:21256596; https://doi.org/10.1016/j.molimm.2010.12.009
   PubMed Web of Science ®Google Scholar
• Zhu J. Mammalian cell protein expression for biopharmaceutical production. Biotechnol Adv 2012; 30(5):1158-70; PMID:21968146; https://doi.org/10.1016/j.biotechadv.2011.08.022
   PubMed Web of Science ®Google Scholar
• Hmiel L, Brorson K, Boyne M, II. Post-translational structural modifications of immunoglobulin G and their effect on biological activity. Anal Bioanal Chem 2015; 407(1):79-94; PMID:25200070; https://doi.org/10.1007/s00216-014-8108-x
   PubMed Web of Science ®Google Scholar
• Sandoz. FDA Arthritis Advisory Committee. BLA 761042 GP2015: a proposed biosimilar to Enbrel (etanercept); 2016. U.S. FDA.
   Google Scholar
• Sandoz. Oncologic Drugs Advisory Committee: ZARXIO (filgrastim); 2015. U.S. FDA.
   Google Scholar
• Carpenter JF, Randolph TW, Jiskoot W, Crommelin DJA, Middaugh CR, Winter G. Potential inaccurate quantitation and sizing of protein aggregates by size exclusion chromatography: Essential need to use orthogonal methods to assure the quality of therapeutic protein products. J Pharm Sci 2010; 99(5):2200-08; PMID:19918982; https://doi.org/10.1002/jps.21989
   PubMed Web of Science ®Google Scholar
• Health Canada. Remsima: Summary basis of decision; 2014.
   Google Scholar
• Feagan BG, Choquette D, Ghosh S, Gladman DD, Ho V, Meibohm B, Zou G, Xu Z, Shankar G, Sealey DC. The challenge of indication extrapolation for infliximab biosimilars. Biologicals 2014; 42(4):177-83; PMID:24962198; https://doi.org/10.1016/j.biologicals.2014.05.005
   PubMed Web of Science ®Google Scholar
• Ahmadi M, Bryson CJ, Cloake EA, Welch K, Filipe V, Romeijn S, Hawe A, Jiskoot W, Baker MP, Fogg MH. Small amounts of sub-visible aggregates enhance the immunogenic potential of monoclonal antibody therapeutics. Pharm Res 2015; 32(4); PMID:25319104; https://doi.org/10.1007/s11095-014-1541-x
   PubMed Web of Science ®Google Scholar
• Paul R, Graff-Meyer A, Stahlberg H, Lauer ME, Rufer AC, Beck H, Briguet A, Schnaible V, Buckel T, Boeckle S. Structure and function of purified monoclonal antibody dimers induced by different stress conditions. Pharm Res 2012; 29(8):2047-59; PMID:22477068; https://doi.org/10.1007/s11095-012-0732-6
   PubMed Web of Science ®Google Scholar
• Bi V, Jawa V, Joubert MK, Kaliyaperumal A, Eakin C, Richmond K, Pan O, Sun J, Hokom M, Goletz TJ, et al. Development of a human antibody tolerant mouse model to assess the immunogenicity risk due to aggregated biotherapeutics. J Pharm Sci 2013; 102(10):3545-55; PMID:23925953; https://doi.org/10.1002/jps.23663
   PubMed Web of Science ®Google Scholar
• Rombach-Riegraf V, Karle AC, Wolf B, Sordé L, Koepke S, Gottlieb S, Krieg J, Djidja M, Baban A, Spindeldreher S, et al. Aggregation of human recombinant monoclonal antibodies influences the capacity of dendritic cells to stimulate adaptive T-cell responses in vitro. PLoS ONE 2013; 9(1):e86322; PMID:24466023; https://doi.org/10.1371/journal.pone.0086322
   PubMed Web of Science ®Google Scholar
• Greenspan L. Humidity fixed points of binary saturated aqueous solutions. Journal of Research of the National Bureau of Standards 1977; 81A(1):89; https://doi.org/10.6028/jres.081A.011
   Google Scholar
• Bern M, Kil YJ, Becker C. Byonic: Advanced peptide and protein identification software. Curr Protoc Bioinformatics 2012; Dec;Chapter 13:Unit 13.20; PMID:23255153; https://doi.org/10.1002/0471250953.bi1320s40
   PubMedGoogle Scholar
• Bern M, Cai Y, Goldberg D. Lookup peaks: A hybrid of de novo sequencing and database search for protein identification by tandem mass spectrometry. Anal Chem 2007; 79(4):1393-1400; PMID:17243770; https://doi.org/10.1021/ac0617013
   PubMed Web of Science ®Google Scholar
• Zhong Y, Hyung S, Ruotolo BT. Characterizing the resolution and accuracy of a second-generation traveling-wave ion mobility separator for biomolecular ions. Analyst 2011; 136(17):3534-41; PMID:21445388; https://doi.org/10.1039/c0an00987c
   PubMed Web of Science ®Google Scholar
• Giles K, Williams JP, Campuzano I. Enhancements in travelling wave ion mobility resolution. Rapid Commun Mass Spectrom 2011; 25(11):1559-66; PMID:21594930; https://doi.org/10.1002/rcm.5013
   PubMed Web of Science ®Google Scholar
• Tito MA, Tars K, Valegard K, Hajdu J, Robinson CV. Electrospray time-of-flight mass spectrometry of the intact MS2 virus capsid. J Am Chem Soc 2000; 122(14):3550-51; https://doi.org/10.1021/ja993740k
   Web of Science ®Google Scholar
• McKay AR, Ruotolo BT, Ilag LL, Robinson CV. Mass measurements of increased accuracy resolve heterogeneous populations of intact ribosomes. J Am Chem Soc 2006; 128(35):11433-42; PMID:16939266; https://doi.org/10.1021/ja061468q
   PubMed Web of Science ®Google Scholar
• Okbazghi SZ, More AS, White DR, Duan S, Shah IS, Joshi SB, Middaugh CR, Volkin DB, Tolbert TJ. Production, characterization, and biological evaluation of well-defined IgG1 fc glycoforms as a model system for biosimilarity analysis. J Pharm Sci 2016; 105(2):559-74; PMID:26869419; https://doi.org/10.1016/j.xphs.2015.11.003
   PubMed Web of Science ®Google Scholar
• Alsenaidy MA, Okbazghi SZ, Kim JH, Joshi SB, Middaugh CR, Tolbert TJ, Volkin DB. Physical stability comparisons of IgG1-Fc variants: Effects of N-Glycosylation site occupancy and asp/gln residues at site asn 297. J Pharm Sci 2014; 103(6):1613-27; PMID:24740840; https://doi.org/10.1002/jps.23975
   PubMed Web of Science ®Google Scholar